-
-
-
ISO 9001:2015 CERTIFIED
ISO 9001:2015 CERTIFIED
Lapatinib API is a dual tyrosine kinase inhibitor targeting HER2 (ErbB2) and EGFR, used in the treatment of HER2-positive metastatic breast cancer. It works by inhibiting intracellular phosphorylation pathways involved in tumor cell proliferation. Lapatinib API is produced under GMP standards and is suitable for oral tablet formulations.
Lapatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 4 (Page 1 of 1)
CAT No.: AS04567
CAS No.: 202197-26-0
Category: Impurities
Parent API: Lapatinib
Mol. Formula: C13H11ClFNO
Mol. Wt.: 251.68
CAT No.: AS04566
CAS No.: 443882-99-3
Category: Impurities
Parent API: Lapatinib
Mol. Formula: C13H9ClFNO3
Mol. Wt.: 281.67
CAT No.: AC0554
CAS No.: NA
Category: Deuterated Standards
Parent API: Lapatinib
Mol. Formula:
Mol. Wt.:
CAT No.: AC0773
CAS No.: 231277-92-2
Category: Working Standards
Parent API: Lapatinib
Mol. Formula: C29H26ClFN4O4S
Mol. Wt.: 581.06
